○Tomoko Okamoto1, Wakiro Sato2, Youwei Lin1, Yuko Shimizu3, Yoichiro Nishida4, Takanori Yokota4, Takami Ishizuka5, Harumasa Nakamura5, Yuji Takahashi1, Takashi Yamamura2 (1.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 3.Department of Neurology, Tokyo Women's Medical University School of Medicine, 4.Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 5.Department of Clinical Research Support, Clinical Research & Education Promotion Division, National Center Hospital, National Center of Neurology and Psychiatry)
Session information
English Poster Session
[Pe-058] English Poster Session 058
Sat. May 21, 2022 1:15 PM - 2:30 PM Poster (Tokyo International Forum E Block B2F Hall E)
Chair:Kazumasa Yokoyama(Juntendo University School of Medicine), Yoko Warabi(Tokyo Metropolitan Neurological Hospital)
○Hiroshi Kuroda1,2, Yoshiki Takai1, Kimihiko Kaneko1, Yuki Matsumoto1, Chihiro Namatame1, Toshiyuki Takahashi1, Tatsuro Misu1, Kazuo Fujihara1,3,4, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Department of Neurology, South Miyagi Medical Center, Japan, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, 4.Southern TOHOKU Research Institute for Neuroscience)
○Kazumasa Yokoyama1, Ryusuke Sato2, Haruki Makioka2, Yuri Al-badri2, Michihiro Kanda2, Takahiko Saida3 (1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Biogen Japan Ltd., 3.Kansai Multiple Sclerosis Center, Kyoto Min-iren Central Hospital)
○John Foley1, Defer Gilles2, Zhovtis Ryerson Lana3, Cohen Jeffrey A.4, Arnold Doug L.5, Butzkueven Helmut6, Cutter Gary7, Giovannoni Gavin8, Killestein Joep9, Wiendl Heinz10, Smirnakis Karen11, Xiao Shan11, Kong George11, Kuhelj Robert11, Campbell Nolan11 (1.Rocky Mountain MS Clinic, USA, 2.Institute of Translational Neurology, University of Munster, 3.Biogen, 4.Centre Hospitalier Universitaire de Caen, 5.NYU Langone Health, New York University, 6.Cleveland Clinic, 7.Montreal Neurological Institute, McGill University, and NeuroRx Research, 8.Central Clinical School, Monash University, 9.University of Alabama School of Public Health, 10.Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 11.MS Centre Amsterdam, VU University Medical Centres)
○Kazuo Fujihara1, Kleiter Ingo2, Traboulsee Anthony3, Palace Jacqueline4, Saiz Albert5, Von Budingen H-christian6, Stokmaier Daniela6, Klingelschmitt Gaelle6, Bennett Jeffrey L7, Yamamura Takashi8 (1.Fukushima Medical University School of Medicine, Japan, 2.Ruhr University Bochum, 3.University of British Columbia, 4.John Radcliffe Hospital, 5.Hospital Clinic and Institut d'Investigacio Biomedica August Pi i Sunyer (IDIBAPS), University of Barcelona, 6.F. Hoffmann-La Roche Ltd, 7.University of Colorado School of Medicine, 8.National Institute of Neuroscience, National Center of Neurology and Psychiatry)